Search by Drug Name or NDC

NDC 00904-6725-80 Sennosides 8.6 mg/1 Details

Sennosides 8.6 mg/1

Sennosides is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is SENNOSIDES.

MedlinePlus Drug Summary

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Related Packages: 00904-6725-80
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna

Product Information

NDC	00904-6725
Product ID	0904-6725_b61d2106-f380-2f9f-e053-2995a90ae468
Associated GPIs	46200060200303
GCN Sequence Number	019964
GCN Sequence Number Description	sennosides TABLET 8.6 MG ORAL
HIC3	D6S
HIC3 Description	LAXATIVES AND CATHARTICS
GCN	00701
HICL Sequence Number	001289
HICL Sequence Number Description	SENNOSIDES
Brand/Generic	Generic
Proprietary Name	Sennosides
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sennosides
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	8.6
Active Ingredient Units	mg/1
Substance Name	SENNOSIDES
Labeler Name	Major Pharmaceuticals
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH NOT FINAL
Application Number	part334
Listing Certified Through	2024-12-31

Package

Package Images

NDC 00904-6725-80 (00904672580)

Pricing Information
NDC Package Code	0904-6725-80
Billing NDC	00904672580
Package	1000 TABLET, FILM COATED in 1 BOTTLE (0904-6725-80)
Marketing Start Date	2018-12-20
NDC Exclude Flag	N
Price Per Unit	0.02383
Pricing Unit	EA
Effective Date	2024-02-21
NDC Description	SENNA 8.6 MG TABLET
Pharmacy Type Indicator	C/I
OTC	Y
Explanation Code	1
Classification for Rate Setting	G
As of Date	2024-02-21

This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

Standard Product Labeling (SPL)/Prescribing Information SPL 27a9d749-cc2c-41ba-8679-8f970b972417 Details

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally causes a bowel movement in 6-12 hours

SPL UNCLASSIFIED SECTION

Do not use

laxative products for longer than one week unless directed by a doctor

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health care professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
Adults and children 12 years of age and older	2 tablets once a day	4 tablets twice a day
Children 6 to under 12 years of age	1 tablet once a day	2 tablets twice a day
Children 2 to under 6 years of age	1/2 tablet once a day	1 tablet twice a day
Children under 2 years of age	ask a doctor	ask a doctor

Other information

Each tablet contains: Calcium 25 mg 
Store at room temperature

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol and talc

Questions or comments?

(800) 616-2471

SPL UNCLASSIFIED SECTION

Tamper Evident:

Do not use if sealed blister units are broken or damaged.

Product color may slightly vary

due to natural changes of ingredients.

Distributed by:

MAJOR® PHARMACEUTICALS

17177 N Laurel Park Drive, Suite 233

Livonia, MI 48152

PRINCIPAL DISPLAY PANEL

NDC 0904-6725-80

MAJOR®

Senna Tablets

Natural Vegetable Laxative Ingredient

For Gentle, Predictable Relief of Constipation

Compare to the active ingredient in Senokot® Tablets*

Sennosides 8.6 mg EACH

1000 TABLETS

INGREDIENTS AND APPEARANCE

SENNA-LAX

sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0904-6522
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSES (UNII: 3NXW29V3WO)
TALC (UNII: 7SEV7J4R1U)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
MALTODEXTRIN (UNII: 7CVR7L4A2D)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	1122;1122
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:0904-6522-61	10 in 1 BOX	03/07/2016
1		10 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part334	03/07/2016

SENNOSIDES

sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0904-6725
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSES (UNII: 3NXW29V3WO)
TALC (UNII: 7SEV7J4R1U)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
MALTODEXTRIN (UNII: 7CVR7L4A2D)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	1122;1122
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:0904-6725-80	1000 in 1 BOTTLE; Type 0: Not a Combination Product	12/20/2018
2	NDC:0904-6725-59	1 in 1 CARTON	12/20/2018
2		100 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part334	12/20/2018

Labeler - Major Pharmaceuticals (191427277)

Revised: 12/2020

Document Id: b61d2106-f380-2f9f-e053-2995a90ae468

Set id: 27a9d749-cc2c-41ba-8679-8f970b972417

Version: 6

Effective Time: 20201210

Search by Drug Name or NDC

NDC 00904-6725-80 Sennosides 8.6 mg/1 Details

Sennosides 8.6 mg/1

MedlinePlus Drug Summary

Product Information

Package

Package Images

NDC 00904-6725-80 (00904672580)

Contents

Standard Product Labeling (SPL)/Prescribing Information SPL 27a9d749-cc2c-41ba-8679-8f970b972417 Details

Drug Facts

Purpose

Uses

SPL UNCLASSIFIED SECTION

Do not use

Ask a doctor before use if you have

Stop use and ask a doctor if

If pregnant or breast-feeding,

Keep out of reach of children.

Directions

Other information

Inactive ingredients

Questions or comments?

SPL UNCLASSIFIED SECTION

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

Questions About Combining Hydroxyzine And Buspirone

Can You Take A Z-Pak If You Have A Penicillin Allergy?